Compare NRO & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NRO | PMI |
|---|---|---|
| Founded | N/A | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.6M | 202.7M |
| IPO Year | 2003 | N/A |
| Metric | NRO | PMI |
|---|---|---|
| Price | $3.08 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 341.3K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.75 | $0.96 |
| 52 Week High | $3.37 | $13.68 |
| Indicator | NRO | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 56.70 | 36.10 |
| Support Level | $3.01 | N/A |
| Resistance Level | $3.11 | $2.45 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 68.18 | 12.01 |
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.